Jump to content

Navy Continues COVID-19 Vaccine Separations as Fourth Vaccine Eyes Conditional FDA Approval


Recommended Posts

Some sailors have received a COVID-19 vaccine that is developed differently from existing vaccines and could overcome religious objections that have been fought over in federal court.

A small percentage of sailors received Novavax COVID-19 while overseas, where the shot is considered approved, said Ed Gulick, a spokesperson for Navy medicine.

Novavax is seeking emergency use authorization from the FDAA for its version of a COVID-19 vaccine. However, that approval could be delayed, according to Axios. Novavax developed a protein-based vaccine, which is a common method for vaccines, against COVID-19. Some have theorized that those uncomfortable with the mRNA vaccines from Pfizer and Moderna due to their reliance on a certain line of fetal cells and idea that the mRNA changes their bodies may be more willing to get the Novavax option, according to science journal Nature.

Link to comment
Share on other sites

Create an account or sign in to comment

You need to be a member in order to leave a comment

Create an account

Sign up for a new account in our community. It's easy!

Register a new account

Sign in

Already have an account? Sign in here.

Sign In Now
  • Who's Online   0 Members, 0 Anonymous, 16 Guests (See full list)

    • There are no registered users currently online


  • Popular Contributors

    Nobody has received reputation this week.

  • 📜 Latest Posts

    1. 0

      Pentagon Unclear How Military Would Manage End of Mandatory COVID-19 Vaccines

    2. 0

      Active Spring 2023 E-4 through E-6 Exams – What You Need to Know

    3. 0

      MARCH 2023 (CYCLE 259) ACTIVE-DUTY AND TRAINING AND ADMINISTRATION OF THE RESERVE (TAR) E-4 THROUGH E-6 ADVANCEMENT

×
×
  • Create New...
Forum Home
www.NavyAdvancement.com
Boots | Navy Patches
Serving enlisted, veterans, spouses & family